Efficient recall of SARS‐CoV‐2 variant‐reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters-Reference-Cited by-同舟云学术

Efficient recall of SARS‐CoV‐2 variant‐reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters

Published:2022-11-16 Issue:1 Volume:95 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Rouers Angeline¹^ORCID,Wong Nathan¹,Goh Yun Shan¹,Torres‐Ruesta Anthony¹,Tay Matthew Zirui¹,Chang Zi Wei¹,Fong Siew‐Wai¹,Neo Vanessa¹,Kam Isaac Kai Jie¹,Yeo Nicholas Kim‐Wah¹,Huang Yuling¹,Loh Chiew Yee¹,Hor Pei Xiang¹,Wong Joel Xu En¹,Tan Yong Jie¹,Macary Paul A.²,Qian Xinlei³,Bei Wang⁴,Ngoh Eve Zi Xian⁴,Salleh Siti Nazihah Mohd⁴,Wang Cheng-I⁴,Poh Xuan Ying⁵,Rao Suma⁵⁶,Chia Po Ying⁵⁶⁷,Ong Sean W. X.⁵⁶,Lee Tau Hong⁵⁶,Lin Ray J. H.⁵⁶,Lim Clarissa⁵,Teo Jefanie⁵,Ren Ee Chee⁴,Lye David Chien⁵⁶⁷⁸,Young Barnaby E.⁵⁶⁷,Ng Lisa F. P.¹⁹¹⁰,Renia Laurent¹⁷⁸,

Affiliation:

1. A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR) Singapore Singapore

2. Department of Microbiology and Immunology, Yong Loo Lin School of Medicine National University of Singapore and National University Health System Singapore Singapore

3. Life Sciences Institute National University of Singapore Singapore Singapore

4. A*STAR Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) Singapore Singapore

5. National Centre for Infectious Diseases Singapore

6. Department of Infectious Diseases Tan Tock Seng Hospital Singapore

7. Lee Kong Chian School of Medicine Nanyang Technological University Singapore

8. School of Biological Sciences Nanyang Technological University Singapore

9. National Institute of Health Research, Health Protection Research Unit in Emerging and Zoonotic Infections University of Liverpool Liverpool UK

10. Institute of Infection, Veterinary and Ecological Sciences University of Liverpool Liverpool UK

Funder

U.S. Food and Drug Administration

Agency for Science, Technology and Research

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.28258

Reference33 articles.

1. RitchieH MathieuE Rodés‐GuiraoL et al. Coronavirus (COVID‐19) vaccinations [Internet]. Accessed July 1 2020. https://ourworldindata.org/covid-vaccinations

2. Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose

3. Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

4. 11 vaccines granted emergency use listing (EUL) by WHO [Internet]. Accessed July 1 2022. https://covid19.trackvaccines.org/agency/who/

5. USFDA.Coronavirus (COVID‐19) update: FDA expands eligibility for COVID‐19 vaccine boosters. US Food and Drug Administration. 2021.https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-covid-19-vaccine-boosters

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trial;eBioMedicine;2024-09

2. Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB;Frontiers in Immunology;2023-07-03